4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Genertec Universal Medical Group Company Limited (2666) operates in the Credit Services industry and is headquartered in Beijing, China with about 23,791 employees. Its market capitalization is roughly CNY 9 billion. In the fiscal year ended 2025-12-31, 2666 reported CNY 14.9B in revenue and CNY 2.2B in net income.
Genertec Universal Medical Group Company Limited, together with its subsidiaries, provides financing, advisory, and medical services in the Mainland China. It operates through two segments, Finance Business and Healthcare Business.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 14.9B | CNY 13.7B | CNY 13.7B | CNY 12.1B | — |
| Gross Profit | CNY 5.0B | CNY 4.6B | CNY 4.6B | CNY 4.5B | — |
| Operating Income (EBIT) | CNY 3.3B | CNY 3.1B | CNY 3.2B | CNY 3.3B | — |
| Net Income | CNY 2.2B | CNY 2.1B | CNY 2.1B | CNY 2.0B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (CNY 616M) | (CNY 615M) | (CNY 592M) | (CNY 580M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 84.3B | CNY 86.0B | CNY 80.3B | CNY 77.0B | — |
| Total Liabilities | CNY 59.3B | CNY 63.2B | CNY 60.0B | CNY 57.3B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2666 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms